Clinical trials
Phase 1 Pancreatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Completed | 5 |
| Recruiting | 4 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cedars-Sinai Medical Center | 2 |
| Mayo Clinic | 2 |
| University Hospital, Geneva | 2 |
| Anhui Provincial Hospital | 1 |
| CorrectSequence Therapeutics Co., Ltd | 1 |
| GlaxoSmithKline | 1 |
| Hayatabad Medical Complex | 1 |
| Indiana University | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Li Gang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatitis | 20 |
| Pancreatitis, Chronic | 4 |
| Hyperlipoproteinemia Type I | 2 |
| Pancreatic Neoplasms | 2 |
| Pancreatitis, Acute Necrotizing | 2 |
| Abdominal Pain | 1 |
| Cerebral Palsy | 1 |
| Cholangiocarcinoma | 1 |
| Chronic Pain | 1 |
| Digestive System Diseases | 1 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.